{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:14:31Z","timestamp":1793646871087,"version":"4.5.1"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ejim.2020.12.023","type":"journal-article","created":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T22:17:31Z","timestamp":1610144251000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"special_numbering":"C","title":["The Brain-Gut-Microbiotal Axis: A framework for understanding functional GI illness and their therapeutic interventions"],"prefix":"10.1016","volume":"84","author":[{"given":"Christopher","family":"Tait","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory S.","family":"Sayuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ejim.2020.12.023_bib0001","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/gutjnl-2014-307843","article-title":"Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis","volume":"64","author":"Ford","year":"2015","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.ejim.2020.12.023_bib0002","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1046\/j.1365-2036.2003.01456.x","article-title":"The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects","volume":"17","author":"Hungin","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.ejim.2020.12.023_bib0003","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1053\/j.gastro.2016.03.035","article-title":"Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction","volume":"150","author":"Drossman","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2020.12.023_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2013.12.015","article-title":"The role of microbiome in central nervous system disorders","volume":"38","author":"Wang","year":"2014","journal-title":"Brain Behav Immun"},{"issue":"6","key":"10.1016\/j.ejim.2020.12.023_bib0005","first-page":"552","article-title":"The impact of gut microbiota on brain and behaviour: implications for psychiatry","volume":"18","author":"Dinan","year":"2015","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"46","key":"10.1016\/j.ejim.2020.12.023_bib0006","doi-asserted-by":"crossref","first-page":"15490","DOI":"10.1523\/JNEUROSCI.3299-14.2014","article-title":"Gut microbes and the brain: paradigm shift in neuroscience","volume":"34","author":"Mayer","year":"2014","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.ejim.2020.12.023_bib0007","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11894-017-0554-0","article-title":"Update on Rome IV Criteria for Colorectal Disorders: Implications for Clinical Practice","volume":"19","author":"Simren","year":"2017","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.ejim.2020.12.023_bib0008","unstructured":"Barrett KE BS. Ganong's Review of Medical Physiology: The Autonomic Nervous System 2010."},{"issue":"5","key":"10.1016\/j.ejim.2020.12.023_bib0009","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nrn3214","article-title":"The economy of brain network organization","volume":"13","author":"Bullmore","year":"2012","journal-title":"Nat Rev Neurosci"},{"issue":"11","key":"10.1016\/j.ejim.2020.12.023_bib0010","doi-asserted-by":"crossref","first-page":"G885","DOI":"10.1152\/ajpgi.00463.2014","article-title":"Animal models of gastrointestinal and liver diseases. Animal models of visceral pain: pathophysiology, translational relevance, and challenges","volume":"308","author":"Greenwood-Van Meerveld","year":"2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"3","key":"10.1016\/j.ejim.2020.12.023_bib0011","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.neuroimage.2009.10.003","article-title":"Complex network measures of brain connectivity: uses and interpretations","volume":"52","author":"Rubinov","year":"2010","journal-title":"Neuroimage"},{"issue":"6","key":"10.1016\/j.ejim.2020.12.023_bib0012","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1053\/j.gastro.2006.10.026","article-title":"Neuroimaging of the brain-gut axis: from basic understanding to treatment of functional GI disorders","volume":"131","author":"Mayer","year":"2006","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.ejim.2020.12.023_bib0013","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jpsychores.2013.03.004","article-title":"Which psychological factors exacerbate irritable bowel syndrome? Development of a comprehensive model","volume":"74","author":"van Tilburg","year":"2013","journal-title":"J Psychosom Res"},{"issue":"1","key":"10.1016\/j.ejim.2020.12.023_bib0014","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.pain.2013.09.020","article-title":"Irritable bowel syndrome in female patients is associated with alterations in structural brain networks","volume":"155","author":"Labus","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.ejim.2020.12.023_bib0015","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1146\/annurev-med-012309-103958","article-title":"The brain-gut axis in abdominal pain syndromes","volume":"62","author":"Mayer","year":"2011","journal-title":"Annu Rev Med"},{"issue":"2","key":"10.1016\/j.ejim.2020.12.023_bib0016","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1523\/JNEUROSCI.2500-07.2008","article-title":"Reduced brainstem inhibition during anticipated pelvic visceral pain correlates with enhanced brain response to the visceral stimulus in women with irritable bowel syndrome","volume":"28","author":"Berman","year":"2008","journal-title":"J Neurosci"},{"issue":"43","key":"10.1016\/j.ejim.2020.12.023_bib0017","doi-asserted-by":"crossref","first-page":"14252","DOI":"10.1523\/JNEUROSCI.1683-14.2014","article-title":"Sex and disease-related alterations of anterior insula functional connectivity in chronic abdominal pain","volume":"34","author":"Hong","year":"2014","journal-title":"J Neurosci"},{"issue":"9","key":"10.1016\/j.ejim.2020.12.023_bib0018","doi-asserted-by":"crossref","first-page":"e73932","DOI":"10.1371\/journal.pone.0073932","article-title":"Sex-related differences of cortical thickness in patients with chronic abdominal pain","volume":"8","author":"Jiang","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.ejim.2020.12.023_bib0019","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jpain.2013.05.009","article-title":"Thicker posterior insula is associated with disease duration in women with irritable bowel syndrome (IBS) whereas thicker orbitofrontal cortex predicts reduced pain inhibition in both IBS patients and controls","volume":"14","author":"Piche","year":"2013","journal-title":"J Pain"},{"issue":"6","key":"10.1016\/j.ejim.2020.12.023_bib0020","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1053\/j.gastro.2013.08.016","article-title":"Impaired emotional learning and involvement of the corticotropin-releasing factor signaling system in patients with irritable bowel syndrome","volume":"145","author":"Labus","year":"2013","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.ejim.2020.12.023_bib0021","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.bbi.2010.11.010","article-title":"Abdominal pain in Irritable Bowel Syndrome: a review of putative psychological, neural and neuro-immune mechanisms","volume":"25","author":"Elsenbruch","year":"2011","journal-title":"Brain Behav Immun"},{"issue":"1","key":"10.1016\/j.ejim.2020.12.023_bib0022","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/j.gastro.2010.07.053","article-title":"Quantitative meta-analysis identifies brain regions activated during rectal distension in irritable bowel syndrome","volume":"140","author":"Tillisch","year":"2011","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.ejim.2020.12.023_bib0023","doi-asserted-by":"crossref","first-page":"G775","DOI":"10.1152\/ajpgi.00155.2012","article-title":"Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome","volume":"303","author":"Camilleri","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.ejim.2020.12.023_bib0024","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/fnsys.2018.00002","article-title":"The Influence of Early Life Experience on Visceral Pain","volume":"12","author":"Fuentes","year":"2018","journal-title":"Front Syst Neurosci"},{"issue":"1","key":"10.1016\/j.ejim.2020.12.023_bib0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00006199-200101000-00004","article-title":"Effect of sexual and physical abuse on symptom experiences in women with irritable bowel syndrome","volume":"50","author":"Heitkemper","year":"2001","journal-title":"Nurs Res"},{"issue":"10","key":"10.1016\/j.ejim.2020.12.023_bib0026","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/nmo.12848","article-title":"The impact of abuse and mood on bowel symptoms and health-related quality of life in irritable bowel syndrome (IBS)","volume":"28","author":"Kanuri","year":"2016","journal-title":"Neurogastroenterol Motil"},{"issue":"3","key":"10.1016\/j.ejim.2020.12.023_bib0027","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1053\/gast.2003.50103","article-title":"Alterations of brain activity associated with resolution of emotional distress and pain in a case of severe irritable bowel syndrome","volume":"124","author":"Drossman","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2020.12.023_bib0028","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3389\/fpsyt.2018.00223","article-title":"Gut-Brain Axis and Mood Disorder","volume":"9","author":"Liu","year":"2018","journal-title":"Front Psychiatry"},{"issue":"7","key":"10.1016\/j.ejim.2020.12.023_bib0029","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/nmo.12358","article-title":"Cytokine imbalance in irritable bowel syndrome: a systematic review and meta-analysis","volume":"26","author":"Bashashati","year":"2014","journal-title":"Neurogastroenterol Motil"},{"issue":"34","key":"10.1016\/j.ejim.2020.12.023_bib0030","doi-asserted-by":"crossref","first-page":"13820","DOI":"10.1523\/JNEUROSCI.1671-13.2013","article-title":"Stress-induced recruitment of bone marrow-derived monocytes to the brain promotes anxiety-like behavior","volume":"33","author":"Wohleb","year":"2013","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.ejim.2020.12.023_bib0031","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nrgastro.2010.4","article-title":"Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions","volume":"7","author":"Ohman","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.ejim.2020.12.023_bib0032","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrmicro2859","article-title":"Categorization of the gut microbiota: enterotypes or gradients?","volume":"10","author":"Jeffery","year":"2012","journal-title":"Nat Rev Microbiol"},{"issue":"6","key":"10.1016\/j.ejim.2020.12.023_bib0033","doi-asserted-by":"crossref","first-page":"572","DOI":"10.4161\/gmic.21772","article-title":"The microbiota link to irritable bowel syndrome: an emerging story","volume":"3","author":"Jeffery","year":"2012","journal-title":"Gut Microbes"},{"issue":"1","key":"10.1016\/j.ejim.2020.12.023_bib0034","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1053\/j.gastro.2007.04.005","article-title":"The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects","volume":"133","author":"Kassinen","year":"2007","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.ejim.2020.12.023_bib0035","doi-asserted-by":"crossref","first-page":"e272","DOI":"10.1111\/nmo.12103","article-title":"The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota","volume":"25","author":"Crouzet","year":"2013","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.ejim.2020.12.023_bib0036","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bbr.2014.07.027","article-title":"Serotonin, tryptophan metabolism and the brain-gut-microbiome axis","volume":"277","author":"O'Mahony","year":"2015","journal-title":"Behav Brain Res"},{"issue":"10","key":"10.1016\/j.ejim.2020.12.023_bib0037","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrn3346","article-title":"Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour","volume":"13","author":"Cryan","year":"2012","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.ejim.2020.12.023_bib0038","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.psyneuen.2014.01.014","article-title":"Absence of the gut microbiota enhances anxiety-like behavior and neuroendocrine response to acute stress in rats","volume":"42","author":"Crumeyrolle-Arias","year":"2014","journal-title":"Psychoneuroendocrinology"},{"issue":"7","key":"10.1016\/j.ejim.2020.12.023_bib0039","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1073\/pnas.1010529108","article-title":"Normal gut microbiota modulates brain development and behavior","volume":"108","author":"Diaz Heijtz","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.ejim.2020.12.023_bib0040","doi-asserted-by":"crossref","first-page":"492","DOI":"10.4161\/cib.15702","article-title":"Effects of intestinal microbiota on anxiety-like behavior","volume":"4","author":"Neufeld","year":"2011","journal-title":"Commun Integr Biol"},{"issue":"3","key":"10.1016\/j.ejim.2020.12.023_bib0041","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1365-2982.2010.01620.x","article-title":"Reduced anxiety-like behavior and central neurochemical change in germ-free mice","volume":"23","author":"Neufeld","year":"2011","journal-title":"Neurogastroenterol Motil"},{"issue":"Pt 1","key":"10.1016\/j.ejim.2020.12.023_bib0042","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1113\/jphysiol.2004.063388","article-title":"Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice","volume":"558","author":"Sudo","year":"2004","journal-title":"J Physiol"},{"issue":"8","key":"10.1016\/j.ejim.2020.12.023_bib0043","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyw020","article-title":"Growing up in a Bubble: Using Germ-Free Animals to Assess the Influence of the Gut Microbiota on Brain and Behavior","volume":"19","author":"Luczynski","year":"2016","journal-title":"Int J Neuropsychopharmacol"},{"issue":"6","key":"10.1016\/j.ejim.2020.12.023_bib0044","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1053\/j.gastro.2010.06.063","article-title":"Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice","volume":"139","author":"Bercik","year":"2010","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.ejim.2020.12.023_bib0045","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.bbi.2010.10.023","article-title":"Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation","volume":"25","author":"Bailey","year":"2011","journal-title":"Brain Behav Immun"},{"issue":"4","key":"10.1016\/j.ejim.2020.12.023_bib0046","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1128\/IAI.00862-09","article-title":"Stressor exposure disrupts commensal microbial populations in the intestines and leads to increased colonization by Citrobacter rodentium","volume":"78","author":"Bailey","year":"2010","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.ejim.2020.12.023_bib0047","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/mp.2016.50","article-title":"From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways","volume":"21","author":"Rogers","year":"2016","journal-title":"Mol Psychiatry"},{"issue":"4","key":"10.1016\/j.ejim.2020.12.023_bib0048","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s11011-014-9507-6","article-title":"Enhancement of functional connectivity, working memory and inhibitory control on multi-modal brain MR imaging with Rifaximin in Cirrhosis: implications for the gut-liver-brain axis","volume":"29","author":"Ahluwalia","year":"2014","journal-title":"Metab Brain Dis"},{"issue":"4","key":"10.1016\/j.ejim.2020.12.023_bib0049","doi-asserted-by":"crossref","first-page":"e60042","DOI":"10.1371\/journal.pone.0060042","article-title":"Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy","volume":"8","author":"Bajaj","year":"2013","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.ejim.2020.12.023_bib0050","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy","volume":"362","author":"Bass","year":"2010","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.ejim.2020.12.023_bib0051","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrgastro.2013.99","article-title":"The liver-brain axis in liver failure: neuroinflammation and encephalopathy","volume":"10","author":"Butterworth","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.ejim.2020.12.023_bib0052","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.amjmed.2015.01.036","article-title":"Irritable bowel syndrome: modern concepts and management options","volume":"128","author":"Sayuk","year":"2015","journal-title":"Am J Med"},{"issue":"Suppl 2","key":"10.1016\/j.ejim.2020.12.023_bib0053","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41395-018-0084-x","article-title":"American College of Gastroenterology Monograph on Management of Irritable Bowel Syndrome","volume":"113","author":"Ford","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.ejim.2020.12.023_bib0054","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/ajg.2017.154","article-title":"ACG and CAG Clinical Guideline: Management of Dyspepsia","volume":"112","author":"Moayyedi","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ejim.2020.12.023_bib0055","doi-asserted-by":"crossref","DOI":"10.1007\/s40265-020-01362-4","article-title":"Functional Dyspepsia: Diagnostic and Therapeutic Approaches","author":"Sayuk","year":"2020","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.ejim.2020.12.023_bib0056","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.gtc.2010.12.003","article-title":"Centrally acting therapies for irritable bowel syndrome","volume":"40","author":"Grover","year":"2011","journal-title":"Gastroenterol Clin North Am"},{"issue":"12","key":"10.1016\/j.ejim.2020.12.023_bib0057","first-page":"980","article-title":"Antidepressant therapy for unexplained symptoms and symptom syndromes","volume":"48","author":"O'Malley","year":"1999","journal-title":"J Fam Pract"},{"issue":"5","key":"10.1016\/j.ejim.2020.12.023_bib0058","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/hup.1038","article-title":"Duloxetine in the treatment of irritable bowel syndrome: an open-label pilot study","volume":"24","author":"Brennan","year":"2009","journal-title":"Hum Psychopharmacol"},{"issue":"3","key":"10.1016\/j.ejim.2020.12.023_bib0059","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/gut.2008.163162","article-title":"Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis","volume":"58","author":"Ford","year":"2009","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.ejim.2020.12.023_bib0060","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1053\/j.gastro.2015.04.020","article-title":"Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled Study","volume":"149","author":"Talley","year":"2015","journal-title":"Gastroenterology."},{"issue":"3","key":"10.1016\/j.ejim.2020.12.023_bib0061","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/gutjnl-2015-310721","article-title":"Efficacy of psychotropic drugs in functional dyspepsia: systematic review and meta-analysis","volume":"66","author":"Ford","year":"2017","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.ejim.2020.12.023_bib0062","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.cgh.2015.09.043","article-title":"Efficacy of Mirtazapine in Patients With Functional Dyspepsia and Weight Loss","volume":"14","author":"Tack","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.ejim.2020.12.023_bib0063","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1365-2036.2008.03633.x","article-title":"Clinical trial: the effect of amitriptyline in patients with diarrhoea-predominant irritable bowel syndrome","volume":"27","author":"Vahedi","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.ejim.2020.12.023_bib0064","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1053\/j.gastro.2018.01.045","article-title":"Best Practice Update: Incorporating Psychogastroenterology Into Management of Digestive Disorders","volume":"154","author":"Keefer","year":"2018","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"10.1016\/j.ejim.2020.12.023_bib0065","first-page":"S1","article-title":"An evidence-based position statement on the management of irritable bowel syndrome","volume":"104","author":"Brandt","year":"2009","journal-title":"Am J Gastroenterol."},{"issue":"8","key":"10.1016\/j.ejim.2020.12.023_bib0066","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1136\/gutjnl-2020-321191","article-title":"Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis","volume":"69","author":"Black","year":"2020","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.ejim.2020.12.023_bib0067","article-title":"Hypnotherapy for treatment of irritable bowel syndrome","author":"Webb","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.ejim.2020.12.023_bib0068","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jpsychores.2008.02.022","article-title":"Hypnotherapy for irritable bowel syndrome: the response of colonic and noncolonic symptoms","volume":"64","author":"Whorwell","year":"2008","journal-title":"J Psychosom Res"},{"issue":"11","key":"10.1016\/j.ejim.2020.12.023_bib0069","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S2468-1253(19)30243-2","article-title":"Cognitive behavioural therapy for irritable bowel syndrome: 24-month follow-up of participants in the ACTIB randomised trial","volume":"4","author":"Everitt","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.ejim.2020.12.023_bib0070","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/1756283X11423706","article-title":"Prucalopride: safety, efficacy and potential applications","volume":"5","author":"Quigley","year":"2012","journal-title":"Therap Adv Gastroenterol"},{"issue":"2","key":"10.1016\/j.ejim.2020.12.023_bib0071","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1365-2982.2004.00615.x","article-title":"The effects of the 5-HT3 antagonist, alosetron, on brain serotonin synthesis in patients with irritable bowel syndrome","volume":"17","author":"Nakai","year":"2005","journal-title":"Neurogastroenterol Motil"},{"issue":"3","key":"10.1016\/j.ejim.2020.12.023_bib0072","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2036.2008.03881.x","article-title":"Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome\u2013results of two randomized, placebo-controlled studies","volume":"29","author":"Drossman","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.ejim.2020.12.023_bib0073","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1517\/14656566.5.11.2369","article-title":"Review of tegaserod in the treatment of irritable bowel syndrome","volume":"5","author":"Patel","year":"2004","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"10.1016\/j.ejim.2020.12.023_bib0074","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1586\/egh.09.72","article-title":"Alosetron for severe diarrhea-predominant irritable bowel syndrome: safety and efficacy in perspective","volume":"4","author":"Lewis","year":"2010","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.ejim.2020.12.023_bib0075","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1517\/14728214.2011.558502","article-title":"Emerging drugs for functional dyspepsia","volume":"16","author":"Tack","year":"2011","journal-title":"Expert Opin Emerg Drugs"},{"issue":"1","key":"10.1016\/j.ejim.2020.12.023_bib0076","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/gutjnl-2014-308188","article-title":"Randomised controlled trial of mesalazine in IBS","volume":"65","author":"Barbara","year":"2016","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.ejim.2020.12.023_bib0077","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/gutjnl-2015-309122","article-title":"A mechanistic multicentre, parallel group, randomised placebo-controlled trial of mesalazine for the treatment of IBS with diarrhoea (IBS-D)","volume":"65","author":"Lam","year":"2016","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.ejim.2020.12.023_bib0078","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2036.2003.01640.x","article-title":"Randomized, double-blind, placebo-controlled trial of prednisolone in post-infectious irritable bowel syndrome","volume":"18","author":"Dunlop","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.ejim.2020.12.023_bib0079","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1136\/gut.2010.213108","article-title":"The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome","volume":"59","author":"Klooker","year":"2010","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.ejim.2020.12.023_bib0080","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1053\/j.gastro.2015.12.034","article-title":"Histamine Receptor H1-Mediated Sensitization of TRPV1 Mediates Visceral Hypersensitivity and Symptoms in Patients With Irritable Bowel Syndrome","volume":"150","author":"Wouters","year":"2016","journal-title":"Gastroenterology."},{"issue":"36","key":"10.1016\/j.ejim.2020.12.023_bib0081","doi-asserted-by":"crossref","first-page":"6593","DOI":"10.3748\/wjg.v23.i36.6593","article-title":"New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond","volume":"23","author":"Sinagra","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.ejim.2020.12.023_bib0082","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1004409","article-title":"Rifaximin therapy for patients with irritable bowel syndrome without constipation","volume":"364","author":"Pimentel","year":"2011","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ejim.2020.12.023_bib0083","first-page":"581","article-title":"Probiotics and prebiotics in the management of irritable bowel syndrome: a review of recent clinical trials and systematic reviews","volume":"14","author":"Whelan","year":"2011","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"4","key":"10.1016\/j.ejim.2020.12.023_bib0084","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/ajcn\/nqy376","article-title":"Prebiotics in irritable bowel syndrome and other functional bowel disorders in adults: a systematic review and meta-analysis of randomized controlled trials","volume":"109","author":"Wilson","year":"2019","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"10.1016\/j.ejim.2020.12.023_bib0085","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1053\/j.gastro.2018.06.045","article-title":"Effects of Prebiotics vs a Diet Low in FODMAPs in Patients With Functional Gut Disorders","volume":"155","author":"Huaman","year":"2018","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ejim.2020.12.023_bib0086","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2016.09.062","article-title":"Colon Hypersensitivity to Distension, Rather Than Excessive Gas Production, Produces Carbohydrate-Related Symptoms in Individuals With Irritable Bowel Syndrome","volume":"152","author":"Major","year":"2017","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.ejim.2020.12.023_bib0087","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/j.1440-1746.2010.06370.x","article-title":"Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome","volume":"25","author":"Ong","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.ejim.2020.12.023_bib0088","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00394-015-0922-1","article-title":"Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis","volume":"55","author":"Marsh","year":"2016","journal-title":"Eur J Nutr"},{"issue":"4","key":"10.1016\/j.ejim.2020.12.023_bib0089","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1053\/j.gastro.2017.06.010","article-title":"A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial","volume":"153","author":"Staudacher","year":"2017","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.ejim.2020.12.023_bib0090","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1136\/gutjnl-2017-313750","article-title":"The low FODMAP diet: recent advances in understanding its mechanisms and efficacy in IBS","volume":"66","author":"Staudacher","year":"2017","journal-title":"Gut"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620520304751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620520304751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:33:11Z","timestamp":1760607191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620520304751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":90,"alternative-id":["S0953620520304751"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2020.12.023","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Brain-Gut-Microbiotal Axis: A framework for understanding functional GI illness and their therapeutic interventions","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2020.12.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.","name":"copyright","label":"Copyright"}]}}